Thursday, March 01, 2012 7:00:39 PM
Wakinyan,
I understand you have experience with this, but lets calm down a minute. You're more abrasive than Nick Burns the Computer Guy. You understand bro?
The Atrinsic link looks like a forwarder that appends the affiliate number so that blucigs knows where the link came from.
When you say "If this client did not go through Atrinsic's affiliate software package, you would get an error message, like error 404 or some such."
Are you saying that if I went to this link: http://www.blucigs.com/store/?utm_source=aff&utm_medium=874696&utm_campaign=4998 without clicking on this link first: http://aan.atrinsic.com/z/874696/4998/&subid1=5869 I would get a 404 error?
I too have experience in this, possibly not as much as you, but we are all here to understand what Atrinsic is up to since we have an investment in it. So if you have to dumb it down for us, please do so without the attitude.
Thanks!
I understand you have experience with this, but lets calm down a minute. You're more abrasive than Nick Burns the Computer Guy. You understand bro?
The Atrinsic link looks like a forwarder that appends the affiliate number so that blucigs knows where the link came from.
When you say "If this client did not go through Atrinsic's affiliate software package, you would get an error message, like error 404 or some such."
Are you saying that if I went to this link: http://www.blucigs.com/store/?utm_source=aff&utm_medium=874696&utm_campaign=4998 without clicking on this link first: http://aan.atrinsic.com/z/874696/4998/&subid1=5869 I would get a 404 error?
I too have experience in this, possibly not as much as you, but we are all here to understand what Atrinsic is up to since we have an investment in it. So if you have to dumb it down for us, please do so without the attitude.
Thanks!
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
